chromium;hydron;N-[7-hydroxy-8-[(2-hydroxy-5-sulfamoylphenyl)diazenyl]naphthalen-2-yl]acetamide;4-hydroxy-3-[(3-methyl-5-oxo-1-phenylpyrazol-4-id-4-yl)diazenyl]benzenesulfonamide

C34H31CrN9O9S2 — CID 121232464

IUPACchromium;hydron;N-[7-hydroxy-8-[(2-hydroxy-5-sulfamoylphenyl)diazenyl]naphthalen-2-yl]acetamide;4-hydroxy-3-[(3-methyl-5-oxo-1-phenylpyrazol-4-id-4-yl)diazenyl]benzenesulfonamide
SMILESCC(=O)Nc1ccc2ccc(O)c(/N=N\c3cc(S(N)(=O)=O)ccc3O)c2c1.Cc1nn(-c2ccccc2)c(=O)[c-]1/N=N\c1cc(S(N)(=O)=O)ccc1O.[Cr].[H+]
InChIInChI=1S/C18H16N4O5S.C16H14N5O4S.Cr/c1-10(23)20-12-4-2-11-3-6-17(25)18(14(11)8-12)22-21-15-9-13(28(19,26)27)5-7-16(15)24;1-10-15(16(23)21(20-10)11-5-3-2-4-6-11)19-18-13-9-12(26(17,24)25)7-8-14(13)22;/h2-9,24-25H,1H3,(H,20,23)(H2,19,26,27);2-9,22H,1H3,(H2,17,24,25);/q;-1;/p+1/b22-21-;19-18-;
InChIKeyHCSLCPGFTGSRHR-CANBOAPGSA-O
MW825.81 g/mol
LogP5.41
Rot. Bonds8

About chromium;hydron;N-[7-hydroxy-8-[(2-hydroxy-5-sulfamoylphenyl)diazenyl]naphthalen-2-yl]acetamide;4-hydroxy-3-[(3-methyl-5-oxo-1-phenylpyrazol-4-id-4-yl)diazenyl]benzenesulfonamide

chromium;hydron;N-[7-hydroxy-8-[(2-hydroxy-5-sulfamoylphenyl)diazenyl]naphthalen-2-yl]acetamide;4-hydroxy-3-[(3-methyl-5-oxo-1-phenylpyrazol-4-id-4-yl)diazenyl]benzenesulfonamide (PubChem CID 121232464) has the molecular formula C34H31CrN9O9S2 and a molecular weight of 825.81 g/mol. Its IUPAC name is chromium;hydron;N-[7-hydroxy-8-[(2-hydroxy-5-sulfamoylphenyl)diazenyl]naphthalen-2-yl]acetamide;4-hydroxy-3-[(3-methyl-5-oxo-1-phenylpyrazol-4-id-4-yl)diazenyl]benzenesulfonamide.

Molecular Properties

Compound Namechromium;hydron;N-[7-hydroxy-8-[(2-hydroxy-5-sulfamoylphenyl)diazenyl]naphthalen-2-yl]acetamide;4-hydroxy-3-[(3-methyl-5-oxo-1-phenylpyrazol-4-id-4-yl)diazenyl]benzenesulfonamide
PubChem CID121232464
Molecular FormulaC34H31CrN9O9S2
Molecular Weight825.81 g/mol
Exact Mass825.11
IUPAC Namechromium;hydron;N-[7-hydroxy-8-[(2-hydroxy-5-sulfamoylphenyl)diazenyl]naphthalen-2-yl]acetamide;4-hydroxy-3-[(3-methyl-5-oxo-1-phenylpyrazol-4-id-4-yl)diazenyl]benzenesulfonamide
SMILESCC(=O)Nc1ccc2ccc(O)c(/N=N\c3cc(S(N)(=O)=O)ccc3O)c2c1.Cc1nn(-c2ccccc2)c(=O)[c-]1/N=N\c1cc(S(N)(=O)=O)ccc1O.[Cr].[H+]
InChIInChI=1S/C18H16N4O5S.C16H14N5O4S.Cr/c1-10(23)20-12-4-2-11-3-6-17(25)18(14(11)8-12)22-21-15-9-13(28(19,26)27)5-7-16(15)24;1-10-15(16(23)21(20-10)11-5-3-2-4-6-11)19-18-13-9-12(26(17,24)25)7-8-14(13)22;/h2-9,24-25H,1H3,(H,20,23)(H2,19,26,27);2-9,22H,1H3,(H2,17,24,25);/q;-1;/p+1/b22-21-;19-18-;
InChIKeyHCSLCPGFTGSRHR-CANBOAPGSA-O
XLogP5.41
TPSA294.44 Ų
H-Bond Donors6
H-Bond Acceptors15
Rotatable Bonds8
Heavy Atoms55
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 500825.81
LogP ≤ 55.41
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'azo_A(324)', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'diazo_group', 'substructure': 'N/A'}

Analyze chromium;hydron;N-[7-hydroxy-8-[(2-hydroxy-5-sulfamoylphenyl)diazenyl]naphthalen-2-yl]acetamide;4-hydroxy-3-[(3-methyl-5-oxo-1-phenylpyrazol-4-id-4-yl)diazenyl]benzenesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of chromium;hydron;N-[7-hydroxy-8-[(2-hydroxy-5-sulfamoylphenyl)diazenyl]naphthalen-2-yl]acetamide;4-hydroxy-3-[(3-methyl-5-oxo-1-phenylpyrazol-4-id-4-yl)diazenyl]benzenesulfonamide?
The IUPAC name of chromium;hydron;N-[7-hydroxy-8-[(2-hydroxy-5-sulfamoylphenyl)diazenyl]naphthalen-2-yl]acetamide;4-hydroxy-3-[(3-methyl-5-oxo-1-phenylpyrazol-4-id-4-yl)diazenyl]benzenesulfonamide (CID 121232464) is chromium;hydron;N-[7-hydroxy-8-[(2-hydroxy-5-sulfamoylphenyl)diazenyl]naphthalen-2-yl]acetamide;4-hydroxy-3-[(3-methyl-5-oxo-1-phenylpyrazol-4-id-4-yl)diazenyl]benzenesulfonamide.
What is the SMILES notation for chromium;hydron;N-[7-hydroxy-8-[(2-hydroxy-5-sulfamoylphenyl)diazenyl]naphthalen-2-yl]acetamide;4-hydroxy-3-[(3-methyl-5-oxo-1-phenylpyrazol-4-id-4-yl)diazenyl]benzenesulfonamide?
The canonical SMILES for chromium;hydron;N-[7-hydroxy-8-[(2-hydroxy-5-sulfamoylphenyl)diazenyl]naphthalen-2-yl]acetamide;4-hydroxy-3-[(3-methyl-5-oxo-1-phenylpyrazol-4-id-4-yl)diazenyl]benzenesulfonamide is CC(=O)Nc1ccc2ccc(O)c(/N=N\c3cc(S(N)(=O)=O)ccc3O)c2c1.Cc1nn(-c2ccccc2)c(=O)[c-]1/N=N\c1cc(S(N)(=O)=O)ccc1O.[Cr].[H+].
What is the InChIKey of chromium;hydron;N-[7-hydroxy-8-[(2-hydroxy-5-sulfamoylphenyl)diazenyl]naphthalen-2-yl]acetamide;4-hydroxy-3-[(3-methyl-5-oxo-1-phenylpyrazol-4-id-4-yl)diazenyl]benzenesulfonamide?
The InChIKey is HCSLCPGFTGSRHR-CANBOAPGSA-O. The full InChI is InChI=1S/C18H16N4O5S.C16H14N5O4S.Cr/c1-10(23)20-12-4-2-11-3-6-17(25)18(14(11)8-12)22-21-15-9-13(28(19,26)27)5-7-16(15)24;1-10-15(16(23)21(20-10)11-5-3-2-4-6-11)19-18-13-9-12(26(17,24)25)7-8-14(13)22;/h2-9,24-25H,1H3,(H,20,23)(H2,19,26,27);2-9,22H,1H3,(H2,17,24,25);/q;-1;/p+1/b22-21-;19-18-;.
What are the key properties of chromium;hydron;N-[7-hydroxy-8-[(2-hydroxy-5-sulfamoylphenyl)diazenyl]naphthalen-2-yl]acetamide;4-hydroxy-3-[(3-methyl-5-oxo-1-phenylpyrazol-4-id-4-yl)diazenyl]benzenesulfonamide?
chromium;hydron;N-[7-hydroxy-8-[(2-hydroxy-5-sulfamoylphenyl)diazenyl]naphthalen-2-yl]acetamide;4-hydroxy-3-[(3-methyl-5-oxo-1-phenylpyrazol-4-id-4-yl)diazenyl]benzenesulfonamide has a molecular weight of 825.81 g/mol, XLogP of 5.41, 8 rotatable bonds, 6 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for chromium;hydron;N-[7-hydroxy-8-[(2-hydroxy-5-sulfamoylphenyl)diazenyl]naphthalen-2-yl]acetamide;4-hydroxy-3-[(3-methyl-5-oxo-1-phenylpyrazol-4-id-4-yl)diazenyl]benzenesulfonamide is sourced from PubChem (CID 121232464), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).